Switzerland Could Become Europe’s First Fully Fledged Adult-Use Market ‘by 2026’
Switzerland has approved a draft proposal to establish a fully commercial adult-use cannabis market.
24 results for “adult-use”
Switzerland has approved a draft proposal to establish a fully commercial adult-use cannabis market.
The Czech government looks to be pursuing a full commercial adult-use cannabis market as part of its ‘Cannabis Management Act’, according to leaked documents seen by Business of Cannabis. It came […]
The pilot in canton Zurich will include up to 7,500 participants and is the first to include a randomised control trial as part of the research.
Insiders suggest the move may be a political ploy to put pressure on the bill’s opponents.
Global sales of adult-use cannabis are projected to double worldwide by 2027.
A new working group will explore the possibility of legalising cannabis for non-medical purposes.
Your weekly debrief of the latest cannabis news.
With the cabinet decision, the Ministry of Health launched its first youth prevention and education campaign.
Researchers found no evidence of an increase in ‘high risk’ use in Canada.
Thousands of Swiss residents have access to legal adult-use cannabis, while patients say they are still struggling to get prescriptions.
Zurich will be the second Swiss city to legalise the sale and consumption of limited amounts of cannabis for personal use.
Major developments are expected in both adult-use and medical cannabis legislation.
Proposals for the introduction of a regulated cannabis market are expected by the end of March.
Researchers found a reduction of 26% in pharmacy-based distribution of codeine in states where cannabis was legal.
Europe’s first trial of adult-use THC cannabis is expected to begin in the new year, Swiss officials have confirmed. Switzerland’s so-called ‘Weed Care’ trial, the first pilot program to study […]
The Cannabis Health Symposium Frankfurt will bring together experts from across Germany’s medical cannabis sector. Here’s what to expect from every session.
Experts will examine the impact of Germany’s cannabis reforms on patient care, prescribing and access to treatment.
After two years of Germany’s Cannabis Act (CanG), the most comprehensive analysis of its impact to date has been published.
Early findings on the impact of the partial legalisation of cannabis suggest no short-term spike in consumption or drug-driving.
The team at Prohibition Partners shares how they think things will shape up for medical cannabis in 2026.
Adults with chronic pain who participated in New York State’s (NYS) Medical Cannabis Program were significantly less likely to require prescription opioids, according to a new study. The study, published […]
Zurich’s flagship adult-use cannabis trial, Züri Can, could now run until 2028 after city officials applied this week to extend the project by two years, citing strong early results in […]
Portugal hosted its seventh international conference on medical cannabis (PTMC) in central Lisbon last week.
Findings from The European Cannabis Report: 10th Edition reflect a decade of immense change across European cannabis markets.